Extrait

To compare the anti-tumor activity of everolimus and sunitinib in subjects with metastatic renal cell carcinoma (mRCC) with non-clear cell pathology.

Critère d'inclusion

• Advanced Non-clear Cell Renal Cell Carcinoma

Liens

• ictrp
• nct